Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Deciphera Pharmaceuticals, Inc. | dcph-20191231.htm |
| EX-32.2 - EX-32.2 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xex322.htm |
| EX-32.1 - EX-32.1 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xex321.htm |
| EX-31.2 - EX-31.2 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xex312.htm |
| EX-31.1 - EX-31.1 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xex311.htm |
| EX-21.1 - EX-21.1 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xexx211.htm |
| EX-10.11 - EX-10.11 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xexx1011.htm |
| EX-4.4 - EX-4.4 - Deciphera Pharmaceuticals, Inc. | dcph-20191231xexx44.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-220866, 333-223992, and 333-230270) and Form S-3 (Nos. 333-227638, 333-233290, and 333-236389) of Deciphera Pharmaceuticals, Inc. of our report dated March 9, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 9, 2020